Literature DB >> 6254554

Antigenic modulation of mammary tumour virus envelope antigen or GR thymic lymphoma cells in relation to expressions of H-2, TL cell-surface antigens and THY1.

J Hilgers, A Sonnenberg, R Nusse.   

Abstract

The MLr antigen, a mammary tumour virus-induced antigen on the surface of GR thymic lymphoma cells (GRSL) can be modulated from the cell surface upon incubation with specific antiserum for 1-2 h at 37 degrees C, followed by washing the cells. In contrast, a number of other cell-surface antigens on these GRSL cells cannot be modulated under similar conditions. These antigens include histocompatibility antigens of the H-2 complex (H-2.8 of the K-end and H-2dx(D) of the H-2dx haplotype) and two thymic markers, TL1.2 and Thy1.2. Antigenic modulation of MLr as tested by trypan-blue exclusion and by chromium51 release does not lead to a measurable change in the expression of H-2K, H-2D, TL and Thy1.2 antigens. These results could be confirmed by absorption analysis. The latter analysis showed that the number of antigenic sites per cell are about the same for MLr and the two H-2 antigens, while TL antigens are scarcer and Thy1.2 antigens are more abundant. The procedure of antigenic modulation showed that the MLr antigen resides on MTVgp52, the major protein of the envelope. There was no evidence of internal proteins, such as MTVp27, on the surface of GRSL cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254554      PMCID: PMC2010442          DOI: 10.1038/bjc.1980.278

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Functional interactions of viral and histocompatibility antigens at tumor cell surfaces.

Authors:  J W Schrader; B A Cunningham; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Modulation of HL-A antigens by anti-HLA antiserum: effects on the cytotoxicity assay and mixed leukocyte reaction.

Authors:  S Sadeghee; J Hebert; J Kelley; N I Abdou
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

3.  Quantitation of virus-induced (MLr) and normal (Thy.1.2) cell surface antigens in isolated plasma membranes and the extracellular ascites fluid of mouse leukemia cells.

Authors:  W J Van Blitterswijk; P Emmelot; J Hilgers; D Kamlag; R Nusse; C A Feltkamp
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

4.  Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.

Authors:  J Hilgers; J Haverman; R Nusse; W J van Blitterswijk; F J Cleton; P C Hageman; P van Nie; J Calafat
Journal:  J Natl Cancer Inst       Date:  1975-06       Impact factor: 13.506

5.  Detection of avian and mammalian oncogenic RNA viruses (oncornaviruses) by immunofluorescence.

Authors:  J Hilgers; R C Nowinski; G Geering; W Hardy
Journal:  Cancer Res       Date:  1972-01       Impact factor: 12.701

6.  Histocompatibility genes (the H-2 complex) and susceptibility to mammary tumor virus in mice.

Authors:  O Mühlbock; A Dux
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

7.  Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.

Authors:  T Aoki; P A Johnson
Journal:  J Natl Cancer Inst       Date:  1972-07       Impact factor: 13.506

8.  Distribution of virus particles and mammary tumor virus antigens in mouse mammary tumors, transformed BALB-c mouse kidney cells, and GR ascites leukemia cells.

Authors:  J Calafat; F Buijs; P C Hageman; J Links; J Hilgers; A Hekman
Journal:  J Natl Cancer Inst       Date:  1974-10       Impact factor: 13.506

9.  Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro.

Authors:  L J Old; E Stockert; E A Boyse; J H Kim
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

10.  Immunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulation.

Authors:  B S Joseph; M B Oldstone
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  3 in total

1.  Antigenic variation in cancer metastasis: immune escape versus immune control.

Authors:  V Schirrmacher; M Fogel; E Russmann; K Bosslet; P Altevogt; L Beck
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

Review 2.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

3.  Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes.

Authors:  K Bosslet; V Schirrmacher
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.